glp 1 agonist anesthesia Patients may consider GLP-1 solely as a Weightloss drug hence not disclosing usage. Patient education and thorough history taking must be emphasised GLP-1 Medication Disclosure Before Anesthesia:
Description
Assessing the safety of sitagliptin in older participants in the trial evaluating cardiovascular outcomes with sitagliptin (TECOS)

doi: 10.1007/BF01225454 [DOI] [PubMed] [Google Scholar] 2

Glucagon-like peptide-1 (GLP-1) receptor agonists: exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review

They will also help manage the legal process

Rahman, S

Moreover, as dosing becomes less frequent, each missed dose carries a much greater clinical impact
